Biomedical Prevention: Testing - The NZ Strategic Context

18
Shaun Robinson Executive Director NZAF

Transcript of Biomedical Prevention: Testing - The NZ Strategic Context

Page 1: Biomedical Prevention: Testing - The NZ Strategic Context

Shaun Robinson

Executive Director NZAF

Page 2: Biomedical Prevention: Testing - The NZ Strategic Context

NZ an Epidemic under Control but not in Decline

Incidence Below the Prevalence Trend

MSM Incidence Below Prevalence Trend

Page 3: Biomedical Prevention: Testing - The NZ Strategic Context

NZ an Epidemic under Control but not in Decline

Page 4: Biomedical Prevention: Testing - The NZ Strategic Context

Success Story for Māori Health

Testing rates lower but increasing

Page 5: Biomedical Prevention: Testing - The NZ Strategic Context

Challenges in Prevention

New Biomedical Tools – TASP and PrEP

+Long Standing Public Health Tools – Condoms, Needle Exchange

How do they Fit together in the NZ Context?

Need clinical and community collaboration and co-ordination

Need a National Strategy

Strategy please

Page 6: Biomedical Prevention: Testing - The NZ Strategic Context

Strategy

Condoms

Test

PrEP

Sexual Health Context

Support for PLHIV/ Stigma Elimination

Cultural Responsiveness

Legal and Human Rights

Treat

Page 7: Biomedical Prevention: Testing - The NZ Strategic Context

NZ an Epidemic under Control but not in Decline

Page 8: Biomedical Prevention: Testing - The NZ Strategic Context

NZ an Epidemic under Control but not in Decline

Testing /Clinical Challenge

20% of MSM and of Africans in NZ who have HIV are undiagnosed

50% of all HIV diagnoses are late

200? People Diagnosed but lost to Care since 2005.

Page 9: Biomedical Prevention: Testing - The NZ Strategic Context

NZ an Epidemic under Control but not in Decline

Testing Challenge

Rapid testing at NZAF since 2006

Increased from 250 pa – 2500 pa

No policy or national consistency

Health system has not adopted rapid testing

Page 10: Biomedical Prevention: Testing - The NZ Strategic Context

NZ an Epidemic under Control but not in Decline

Testing TacticsOutreach to :

• Venues• Events• Suburbs

Partnering with others to support rapid testing• Marae• GPs• Body positive• Asian• Pacific

Page 11: Biomedical Prevention: Testing - The NZ Strategic Context

NZ an Epidemic under Control but not in Decline

Testing TacticsHome Testing pilot

Exploring other models

Working towards national strategy

Page 12: Biomedical Prevention: Testing - The NZ Strategic Context

New Zealand 30 Years into the Epidemic…

A Lot to Loose …

Low Prevalence

A Lot to Gain …

Persistent Incidence

Page 13: Biomedical Prevention: Testing - The NZ Strategic Context

NZ an Epidemic under Control but not in Decline

Condom Use Challenges

95% positive attitudes to condom use (GAPSS GOSS research)

Close the GAP

80% high condom use

Page 14: Biomedical Prevention: Testing - The NZ Strategic Context

New Science New Opportunities

PARTNER Study - TASP

PROUD and IPERGAY - PrEP

Page 15: Biomedical Prevention: Testing - The NZ Strategic Context

No one uses

Condoms

Most people use Condoms

A new medication

Day to Day Focus Can Pull Us Apart

Page 16: Biomedical Prevention: Testing - The NZ Strategic Context

PrEP

A small targeted role

For people who resist condom use and are able to manage adherence

Requires Clinical Oversight – HIV testing, STI testing, Adherence monitoring, Condom promotion, Support

Best managed by sexual health physicians as people using PrEP will definitely risk repeated STI infections

Page 17: Biomedical Prevention: Testing - The NZ Strategic Context

PrEP Project New Zealand

No funding

Voluntary project being developed with Auckland Sexual Health

Need to put definition around PrEP in NZ• Access Criteria• Clinical Protocols/ Guidelines

Test demand and effectiveness in real world in NZ

Gain experience which will guide future developments

Page 18: Biomedical Prevention: Testing - The NZ Strategic Context

Clinical and Community Collaboration